In this guide
What does this guide compare?
Perceived stress and diagnosed anxiety disorders require different evidence.
This collection compares products discussed around one topic. It is not a protocol to take in full. Links to individual profiles appear after the article.
| Reference point | Context |
|---|---|
| Products compared | 5 |
| Evidence scope | Ingredient, formulation, population and measured outcome |
| Complete combination | The cited studies do not automatically validate all members together |
Which products are compared?
Ashwagandha, L-Theanine, Magnesium, B-Complex, Fish Oil (EPA/DHA).
Individual profiles describe formulation, source-reported amounts, tolerability and interactions. Those details remain ingredient-specific. An amount studied alone is not automatically appropriate in a combination.
How do their roles differ?
Stress symptoms, anxiety disorders and nutritional deficiency are separate clinical questions. Ashwagandha extracts are investigated for stress-related responses; magnesium and B vitamins have nutritional roles. A proposed effect on cortisol does not establish treatment of an anxiety disorder. [1][2][3]

Selected ingredient studies and their limits
These examples compare distinct preparations and outcomes. Their schedules describe research and are not a regimen to combine.
Ashwagandha. the 2026 AshwaSR trial randomized 135 stressed adults to the same sustained-release root extract at 150 or 300 mg once daily after breakfast, or placebo, for 60 days. Several questionnaire outcomes favored the extract; 126 completed. Manufacturer funding and sponsor/vendor author employment limit independence. This does not establish equivalence with another extract or a benefit from a multi-ingredient combination. [6], [2]
What does the research show?
The 2026 AshwaSR trial randomized 135 stressed adults and assessed outcomes over 60 days. Perceived stress and some related outcomes improved compared with placebo, but the study concerned one sustained-release extract. Its results cannot validate every extract, theanine-containing blend or combined stack, and a short trial cannot exclude rare liver injury. [1][2][3]
An observational association, a laboratory finding and a perceived benefit answer different questions. Randomized trials need their comparator, duration and population kept in view. An inconclusive result does not establish that an effect is impossible; it limits the claim that can be made.

Which overlaps and risks matter?
Cautions and interactions
Ashwagandha warrants pregnancy, thyroid, autoimmune and medication precautions. Sedative medicines and multiple calming products may overlap. A change in perceived stress can also reflect sleep, workload or concurrent therapy; it is not proof of a hormone-correcting effect. [1][2][3]
A complete product list includes prescription medicines, nonprescription products and supplements. Combination formulas can conceal duplicate ingredients. Timing and spacing from a medicine should follow its labeling and pharmacist guidance; this collection does not supply a universal timetable.
Regulatory status
In the United States, FDA does not approve dietary supplements for safety and effectiveness before marketing. In Canada, a natural health product requires a product licence before sale; its NPN or DIN-HM must match the finished product. An ingredient name or inclusion in this collection does not establish that every product or claim is authorized. Authorization also does not validate the complete combination. [4], [5]
What should be recorded and how should changes be interpreted?
Doserly brings dose logs, symptoms and routine changes together. For this collection, useful observations include perceived stress, sleep quality, daytime function, workload, medication changes and adverse effects.
- Doses and adherence: record the formulation, amount actually taken, timing and missed doses so observations have context.
- Potential benefits and tolerability: compare consistent symptoms or measurements over time alongside sleep, food and activity changes. Personal trends help evaluate the experience without proving causal efficacy.
- Product list: maintain the full product list for review with a pharmacist or clinician.
- AI monthly reports: summarize recorded doses, symptoms and trends to prepare for a discussion. Reports depend on the data entered and are not a diagnosis or an instruction to change treatment.
Explore the topic further
Common questions
Do these trials establish treatment of an anxiety disorder?
No. A stress-questionnaire result in selected stressed adults does not establish treatment of a diagnosed anxiety disorder. The preparation, eligibility criteria and measured outcome limit the claim. [1], [2], [6]
Are all ashwagandha extracts equivalent to AshwaSR?
No. The cited trial tested a particular sustained-release root extract over 60 days. Another plant part, extraction process or combination formula is not automatically equivalent. [2], [6]
Is a short trial enough to rule out rare liver injury?
No. Rare adverse events may not appear in a small, short trial. Public guidance also identifies thyroid, autoimmune, pregnancy and medication precautions. [1], [6]
How can tracking make the experience more interpretable?
Record product changes alongside sleep, workload, symptoms and medicines. Changing several factors together makes the cause of an improvement unclear. Doserly can preserve the timeline; it does not diagnose anxiety or prove an ingredient’s effect.
Glossary
Terms for interpreting the comparisons.
- Formulation
- The exact preparation, including its ingredients, their forms and labeled amounts.
- Study population
- The people included in a study; their characteristics limit where its result applies.
- Comparator
- The placebo, treatment or condition used as the comparison.
- Measured outcome
- What the study evaluates, such as a symptom, laboratory result or clinical event.
- Overlap
- The same ingredient appearing in more than one product used together.
How was this guide researched?
Sources and limits
This AI-assisted educational guide compares the cited public references. Findings remain tied to the ingredients, preparations and populations studied. It is not a systematic review or independent medical peer review. Doserly develops a commercial tracking app. Illustrations explain concepts; app screens show example data. Report a correction with its source to Doserly support.
Explore the sources
The references below provide context for the claims and their limits.
Showing 6 sources
- 01
- 02
Efficacy and safety of Ashwagandha root extract sustained-release (AshwaSR) capsules in healthy adult, stressed subjects: A randomized, double-blind, placebo-controlled, parallel-group, 3-arm clinical trial. ↗
Public reference
Check the reported population, preparation and limitations.
- 03
NCCIH — Herb–drug interactions ↗
Public reference
Check the reported population, preparation and limitations.
- 04
FDA — Questions and Answers on Dietary Supplements ↗
Regulatory reference
United States dietary supplement regulation.
- 05
- 06
Ashwagandha: Health Professional Fact Sheet ↗
Official summary
Stress, sleep, safety, thyroid and liver-injury overview.
Full text checked October 9, 2026.
No matching sources
Try a different term or show the full list.